Social justice

The Dr. N. Joyce Payne Center for Social Justice publishes first volume in new book series

Retrieved on: 
Wednesday, March 27, 2024
Employment, Series, Social justice, Thurgood Marshall College Fund, Education, Public policy, University of Southern Mississippi, Research, Hope, Social, HBCU, Investment, DRS, Future, Workforce, Gallup, Optimism, Management

Washington, D.C., March 27, 2024 (GLOBE NEWSWIRE) -- The Dr. N. Joyce Payne Center for Social Justice of the Thurgood Marshall College Fund (TMCF) recently published its first volume in The Payne Center Book Series , which focuses on pragmatic policy ideas related to social justice.

Key Points: 
  • Washington, D.C., March 27, 2024 (GLOBE NEWSWIRE) -- The Dr. N. Joyce Payne Center for Social Justice of the Thurgood Marshall College Fund (TMCF) recently published its first volume in The Payne Center Book Series , which focuses on pragmatic policy ideas related to social justice.
  • “This first volume sets the bar for the upcoming series, as we continue to examine the intersectionality of educational, economic and environmental justice in American society,” Dr. N. Joyce Payne , founder of TMCF, said.
  • The Payne Center is responsible for producing innovative social justice research; leveraging social justice research to inform public policy; supporting the research and educational missions of HBCUs; and advancing diversity, equity and inclusion in the workforce.
  • The Payne Center for Social Justice and Gallup recently released “ Black Thriving in America 2023 ,” which assessed Black life experiences in the United States and produced the groundbreaking Black American Social Justice Dashboard.

Opill and WNBA Team Up for Groundbreaking Partnership

Retrieved on: 
Tuesday, April 9, 2024
Consumer, National Basketball Association, Organization, Birth, Sport, Health equity, Social justice, Partnership, Pharmacy, Draft, NBA scoring leaders, Student, Perrigo, OTC, WNBA draft, WNBA, FDA, Health education, Food

GRAND RAPIDS, Mich. and NEW YORK, April 9, 2024 /PRNewswire/ -- Today, Perrigo Company plc, a leading provider of Consumer Self-Care Products, announced that Opill® — the first-ever daily birth control pill available without a prescription in the U.S. — and the Women's National Basketball Association (WNBA) have entered a multi-year partnership that focuses on building confidence, strength and health equity, all of which closely align with both organizations' core priorities.

Key Points: 
  • "Opill® is changing the game in reproductive health, just like the WNBA's game-changing role in sports and pop culture," said Leila Bahbah, Perrigo U.S. Women's Health Brand Lead.
  • Opill® will tip off the relationship as an Associate Partner of the 2024 WNBA Draft presented by State Farm on April 15 in Brooklyn, New York.
  • This season, the WNBA is concentrating its social justice efforts into two areas: civic engagement and reproductive health advocacy.
  • Opill® and the WNBA are also collaborating on a program to reach students on college campuses nationwide.

European Parliament Recognizes Essential Tremor as Official Disease in Ground-Breaking Declaration

Retrieved on: 
Tuesday, April 9, 2024
European Parliament, Myenteric plexus, Movement disorder, Environment, Disease, Social justice, Patient, DSM-IV codes, Joint Declaration, Hope, Quality of life, Parliament, Essential tremor, European, Geography, Insightec, Pharmaceutical industry

BRUSSELS, April 9, 2024 /PRNewswire/ -- The European Parliament, in collaboration with Insightec and patient advocacy groups, has taken a historic step forward in the healthcare realm by signing a Joint Declaration to officially recognize essential tremor as a disease. This monumental move promises to enhance the lives of millions who suffer from the most common movement disorder worldwide, affecting an estimated 54 million people.

Key Points: 
  • The Joint Declaration specifically calls for the following:
    The formal recognition of essential tremor as a distinct disease.
  • "Access to treatment options for essential tremor is a matter of equality and social justice," echoes Maarit Matjussi, chair of ScanShakers and chairwoman of the Finnish Essential Tremor Association.
  • "Signing this Joint Declaration, together with Members of the European Parliament and patient associations across Europe, is a pivotal milestone for Insightec and for people living with essential tremor across Europe.
  • Members of the European Parliament, Insightec, and patient groups are united in their commitment to ensuring equal therapy access and improving quality of life for all affected by this disease.

Verge Genomics and Ferrer Announce Agreement to Co-Develop Clinical-Stage ALS Therapy VRG50635

Retrieved on: 
Monday, March 25, 2024
Survival, Verge, ALS, Caregiver, Social justice, Partnership, Patient, SAN, Tissue, News, Business development, Ferrer, POC, Neuron, B Corporation (certification), Clinical trial, Genomics, DSM-IV codes, Drug development, Safety, CONVERGE, Pharmaceutical industry

VRG50635 is a potential best-in-class, small molecule inhibitor of PIKfyve, a therapeutic target for ALS discovered in diseased human tissues using CONVERGE®, Verge’s all-in-human, AI-powered platform.

Key Points: 
  • VRG50635 is a potential best-in-class, small molecule inhibitor of PIKfyve, a therapeutic target for ALS discovered in diseased human tissues using CONVERGE®, Verge’s all-in-human, AI-powered platform.
  • Under the terms of the agreement, Ferrer will obtain the exclusive rights to co-develop and commercialize VRG50635 for ALS in multiple regions outside of the United States of America.
  • Verge has retained all rights to development and commercialization for VRG50635 for all uses in the United States and all countries outside the agreement.
  • “We're thrilled to work with Ferrer to progress VRG50635 through clinical development and towards potential commercialization.

National Civil Rights Museum welcomes Martin Luther King III and his family for a commemoration to honor his father’s legacy on the 56th Anniversary of Dr. Martin Luther King Jr.’s tragic death

Retrieved on: 
Friday, March 15, 2024
Homelessness, Racism, Museum, Climate change, Bishop, Metropolitan, Social justice, Spirituals, Education, National Civil Rights Museum, Violence, Black, Death, Life, Poverty, Poetry, Rain, Weather, Drum Major Institute, Community Alliance, Social change, Human, Movement, DMI

Martin Luther King III, wife Arndrea Waters King, and daughter Yolanda Renee King will participate in the ceremony, which will be live streamed for those who cannot attend in person.

Key Points: 
  • Martin Luther King III, wife Arndrea Waters King, and daughter Yolanda Renee King will participate in the ceremony, which will be live streamed for those who cannot attend in person.
  • This year, the Museum introduces a youth component with the performing winners of its Youth Poetry and Spoken Word Competition.
  • Martin Luther King III, the oldest son of the late Dr. Martin Luther King Jr. and Mrs. Coretta Scott King, will deliver the keynote address.
  • Mr. King is a civil rights advocate and global humanitarian, focusing on addressing the most pressing social justice issues of today.

ImpactMapper integrates with Trint to Expedite Impact Reporting and Analysis of Interviews and Reports

Retrieved on: 
Thursday, March 14, 2024
UX, CRM, AP, IKEA, Woman, Data analysis, Financial Times, Social justice, Salesforce, DLA, Malala Fund, Fluxx, Interview, Doctor of Philosophy, Life, Piper, Data collection, UNDP, API, UN Women, DLA Piper, BBC, UN

“ImpactMapper is the only impact reporting tool on the market that takes qualitative data seriously. This is incredibly important as groups all over the world are making critical social justice, equity, and environmental changes that affect rights, policies, and norms. The changes and impact they are making come to life when they are contextualized and deeper examples and stories of changes are shared. As such, we often recommend to the foundations and donors that we work with to move to oral reporting formats to better track this type of impact and to decrease the reporting burden on their partners. We also underscore the importance of qualitative data, such as interviews and focus groups, for landscaping, context, and outcome analysis. In this effort to move to trust-based reporting practices in philanthropy, transcription tools like Trint are often used. The integration with ImpactMapper strengthens trust-based reporting practices in philanthropy and gives a concrete set of tools to make this happen. The integration also supports ImpactMapper in opening up to other markets, such as journalists, companies, UX experts, and other users of Trint software that are interested in tagging their audio and video transcripts thematically, aggregating trends, and visualizing data trends across a set of stories, interviews or clients.” -- Alexandra Pittman, PhD, Founder and CEO, ImpactMapper  

Key Points: 
  • After users record an interview, focus group, or grantee reporting session in Trint, they can automatically import Trint transcripts into ImpactMapper for deeper analysis and visualization.
  • This real-time integration saves users valuable time, ensures they always have access to the newest reports and interviews and helps to ensure that transcripts are analyzed and used for impact reporting.
  • ImpactMapper has robust qualitative text analysis tools, in addition to financial and quantitative analysis and a survey tool, creating an all-in-one flexible data analysis, visualization, and impact reporting solution for users.
  • A set of equitable AI and autocoding tools is also being developed in 2024 to make impact reporting even more efficient through the ImpactMapper software.

Today’s Youth to Add Their Voices at the Second Annual Freedom of Mobility Forum

Retrieved on: 
Thursday, March 14, 2024
Climate change, HEC Paris, Advisory board, Q&A, University, Brandeis University, Environment, Social justice, EQUITY, Freedom, Research, Transport, Student, Social policy, Mobility, Nursing

Conceived by Stellantis as an open forum for the public to hear a broad range of perspectives as society faces the mobility challenges of the future, the Freedom of Mobility Forum’s second annual live debate promises to bring diverse – and possibly controversial – opinions.

Key Points: 
  • Conceived by Stellantis as an open forum for the public to hear a broad range of perspectives as society faces the mobility challenges of the future, the Freedom of Mobility Forum’s second annual live debate promises to bring diverse – and possibly controversial – opinions.
  • The event on April 3 will be facilitated by a neutral third-party and will explore how planetary limits could reshape freedom of mobility from technology, business, and lifestyle perspectives.
  • Their research covers the major factors driving inequities in access to transportation and identifies relevant pathways to fostering greater mobility equity and accessibility for all.
  • They are exploring alternative and creative solutions that can offer more affordable, scalable, and sustainable mobility options that can better address environmental and social challenges.

Wilson Sonsini Files Pro Bono Lawsuit Against USDA Alleging Discrimination Against Farmers of Color

Retrieved on: 
Monday, April 1, 2024
Class Action Lawsuit, Professional Services, Legal, Census of agriculture, USDA, Farmer, Government, Pigford, White, Social justice, Federation, District court, Livestock, History, Seed, Provost, Heart, Torture, Private law, Medicare, Family, Weather, Agriculture

The lawsuit was filed on behalf of pro bono clients, Angie and Wenceslaus (June) Provost Jr., along with a proposed class, in response to alleged discriminatory practices against Black and minority farmers.

Key Points: 
  • The lawsuit was filed on behalf of pro bono clients, Angie and Wenceslaus (June) Provost Jr., along with a proposed class, in response to alleged discriminatory practices against Black and minority farmers.
  • Furthermore, the complaint alleges that the agency has been negligent in promptly addressing discrimination claims and has proceeded with foreclosure on farmers with pending complaints.
  • As a result, significant barriers to economic mobility have been created, and generations of disenfranchisement have been perpetuated.
  • The firm has long engaged in successful large-scale pro bono litigation, encompassing a diverse range of cases.

Application Window Now Open for The Sallie Mae Fund’s Bridging the Dream Scholarship Program

Retrieved on: 
Monday, March 25, 2024
Finance, Professional Services, Philanthropy, DEI (Diversity, Equity and Inclusion), Fund Raising, University, Other Philanthropy, Primary, Secondary, Education, Education minister, SLM, Social justice, Thurgood Marshall College Fund, Partnership, Sallie Mae, Student, Multimedia, Nursing

View the full release here: https://www.businesswire.com/news/home/20240325903994/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240325903994/en/
    The Sallie Mae Fund will again offer its Bridging the Dream Scholarship for High School Students , increasing the number of scholarships awarded from 25 to 40.
  • “These transformative scholarships empower students to bridge the gap between aspiration and accomplishment, turning their dream of a degree into reality.”
    In addition to The Bridging the Dream Scholarship Program, Sallie Mae connects students to millions of scholarships through its free resource, Scholly by Sallie.
  • The application window for both The Bridging the Dream Scholarship for High School Seniors and The Bridging the Dream Scholarship for Graduate Students is open until May 17, 2024.
  • Commonly known as Sallie Mae, SLM Corporation and its subsidiaries are not sponsored by or agencies of the United States of America.

Verge Genomics and Ferrer Announce Agreement to Co-Develop Clinical-Stage ALS Therapy VRG50635

Retrieved on: 
Monday, March 25, 2024
Technology, Neurology, Genetics, Clinical Trials, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Artificial Intelligence, Survival, Verge, ALS, Caregiver, Social justice, Partnership, Patient, Tissue, News, Ferrer, POC, Neuron, B Corporation (certification), Clinical trial, Genomics, DSM-IV codes, Drug development, Safety, Pharmaceutical industry

VRG50635 is a potential best-in-class, small molecule inhibitor of PIKfyve, a therapeutic target for ALS discovered in diseased human tissues using CONVERGE®, Verge’s all-in-human, AI-powered platform.

Key Points: 
  • VRG50635 is a potential best-in-class, small molecule inhibitor of PIKfyve, a therapeutic target for ALS discovered in diseased human tissues using CONVERGE®, Verge’s all-in-human, AI-powered platform.
  • Under the terms of the agreement, Ferrer will obtain the exclusive rights to co-develop and commercialize VRG50635 for ALS in multiple regions outside of the United States of America.
  • Verge has retained all rights to development and commercialization for VRG50635 for all uses in the United States and all countries outside the agreement.
  • “We're thrilled to work with Ferrer to progress VRG50635 through clinical development and towards potential commercialization.